News | Ultrasound Imaging | November 20, 2025

Collaboration aims to expand existing U.S. relationship combining GE’s mammography systems with DeepHealth’s Breast Suite to include worldwide distribution; integrate GE’s ultrasound imaging with DeepHealth’s Thyroid Suite; and create a proposed offering combining DeepHealth’s remote scanning solution with GE’s ultrasound product portfolio.

GE Healthcare, DeepHealth to Expand Collaboration

DeepHealth TechLive Command Center
(Photo: DeepHealth)


Nov. 12, 2025 — GE HealthCare  and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their intention to expand their existing strategic collaboration to further the innovation, commercialization and adoption of AI across multiple imaging modalities. The companies plan to broaden their existing collaboration to include a wider suite of AI tools aimed at enhancing breast cancer care and extending these offerings to new regions outside the United States. The companies also plan to work together to bring new automation and remote connectivity tools to ultrasound, helping to enhance diagnostic confidence and expanding access to expert care across diverse settings.

The expanded collaboration builds on the joint initiative first announced in 2024, which united DeepHealth’s AI-powered breast cancer screening workflow solution with GE HealthCare’s Senographe Pristina mammography system to enhance image interpretation and improve operational efficiency.

This next phase of the relationship aims to expand the successful collaboration in three areas:

  • By extending access to breast cancer solutions worldwide.
  • Integrating GE HealthCare’s ultrasound imaging with DeepHealth’s AI-powered Thyroid Suite for intelligent clinical decision support and reporting automation.
  • Bringing DeepHealth’s TechLive remote scanning solution together with GE HealthCare’s ultrasound portfolio.

The two companies aspire to empower clinicians and technologists, optimize patient pathways and improve patient access and outcomes.

“Our relationship with DeepHealth is a powerful example of how we are advancing our precision care through intelligent technology and a collaborative platform strategy,” said Karley Yoder, Chief Executive Officer of Comprehensive Care Ultrasound, Advanced Visualization Solutions at GE HealthCare. “We look forward to incorporating DeepHealth Thyroid Suite and TechLive into our ultrasound portfolio, and enhancing the capabilities of clinicians to make faster, more confident decisions while helping ensure patients benefit from the best our technology can offer.”

“Together with GE HealthCare, we are advancing a new standard of AI-powered care for better outcomes, improved patient experience and more efficient workflows,” said Kees Wesdorp, President and Chief Executive Officer of RadNet’s Digital Health Division, DeepHealth. “By uniting imaging, informatics and AI, we aim to detect disease earlier and more accurately, enable greater operational efficiency and increase patient access to high-quality care.”

Ultrasound imaging can be complex and challenging, and its quality is heavily dependent upon the skills and experience of the sonographer. Traditional thyroid ultrasound workflows require extensive manual measurements, repetitive worksheet creation and time-consuming reporting processes that may strain staff and impact patient experience.

DeepHealth Thyroid Suite is an AI-powered suite of modular applications designed to seamlessly integrate into existing thyroid imaging workflows and technology, to standardize care,1,2 and deliver critical workflow efficiency.3 By automating nodule detection, characterization and standardizing worksheets and reporting, Thyroid Suite applications can help radiologists and sonographers work more efficiently and consistently.4 RadNet, a leading imaging services provider in the United States, has shown up to a 30% reduction in exam time as a result of increased workflow efficiency.3 In addition, radiologists using Thyroid AI-generated reports in more than 4,070 nodules accepted those reports without correction in greater than 94% of the cases.1,5

The planned collaboration will also include GE HealthCare distributing DeepHealth’s TechLive remote scanning for use with GE HealthCare’s ultrasound products. The combined solution empowers clinicians to remotely perform or supervise ultrasound across multiple locations from a single, secure location. This allows expert care teams to guide sonographers in real-time, helping improve access to ultrasound imaging regardless of geographic location or staffing constraints.

GE HealthCare and DeepHealth will both exhibit at the Radiological Society of North America (RSNA) Meeting, Nov. 30 – Dec. 4 in Chicago. GE HealthCare will host a panel discussion with DeepHealth in booth #8355 at its Ultrasound Precision Care Education Room on Dec. 2, at 4 p.m. CT and will also host demonstrations of TechLive. The same educational session will be hosted at the DeepHealth Immersive Theater in booth #1329.

 

References

  1. DeepHealth’s AI improves radiologist’s characterization of TI-RADS descriptors and level agreement. Data on file. Summary of Performance Testing Studies, Thyroid 510(k) clearance.
  2. DeepHealth’s AI model matches clinical expertise. Data on file. “Evaluation of AI-enhanced Thyroid Ultrasound Reporting Software for Improved Diagnostic Consistency.”
  3. Demonstrated up to a 30% reduction in scan slot time. Results from early solution deployment on RadNet sites.
  4. DeepHealth Thyroid Suite includes DeepHealth Viewer and DeepHealth Thyroid AI. DeepHealth Viewer is Manufactured as eRAD PACS by eRAD and Distributed by DeepHealth. DeepHealth Thyroid AI is manufactured as See-Mode Augmented Reporting Tool, Thyroid (SMART-T) by See-Mode for DeepHealth Inc. Any claims made about Thyroid Suite may reference claims associated with its individual components.
  5. Data on file. Comparison of final radiologist reports and DeepHealth’s Thyroid AI reports in 1,466 studies and 4,070 nodules analyzed between 14 August and 29 August 2025.

Related Content

News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 05, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Interventional Radiology

Feb. 2, 2026 — GE HealthCare has announced that Allia Moveo has received U.S. Food and Drug Administration (FDA) 510(k) ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
Subscribe Now